Display options
Cite
Sinha R, Lockman KA. Editorial: screening for NAFLD - a promising strategy to mitigate future burden of liver disease. Aliment Pharmacol Ther. 2016;43(1):163doi: 10.1111/apt.13421.
Sinha, R., & Lockman, K. A. (2016). Editorial: screening for NAFLD - a promising strategy to mitigate future burden of liver disease. Alimentary pharmacology & therapeutics, 43(1), 163. https://doi.org/10.1111/apt.13421
Sinha, R, and Lockman, K A. "Editorial: screening for NAFLD - a promising strategy to mitigate future burden of liver disease." Alimentary pharmacology & therapeutics vol. 43,1 (2016): 163. doi: https://doi.org/10.1111/apt.13421
Sinha R, Lockman KA. Editorial: screening for NAFLD - a promising strategy to mitigate future burden of liver disease. Aliment Pharmacol Ther. 2016 Jan;43(1):163. doi: 10.1111/apt.13421. PMID: 26638929.
Copy Download .nbib Format: NLM
Share it on

Aliment Pharmacol Ther. 2016 Jan;43(1):163. doi: 10.1111/apt.13421.

Editorial: screening for NAFLD - a promising strategy to mitigate future burden of liver disease.

Alimentary pharmacology & therapeutics

R Sinha, K A Lockman

Affiliations

  1. Department of Hepatology, Royal Infirmary of Edinburgh, Edinburgh, UK.
  2. Department of Acute Medicine, Royal Infirmary of Edinburgh, Edinburgh, UK. [email protected].

PMID: 26638929 DOI: 10.1111/apt.13421

[No abstract available.]

MeSH terms

Publication Types